| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 | Jun'17 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||||
Net (loss) income | ||||||||||
-1,966 | - | - | - | 3,995 | - | - | - | - | - | - |
Non-cash items included in net (loss) income: | ||||||||||
Depreciation and amortization of property and equipment | ||||||||||
4,900 | - | - | - | 6,000 | - | - | - | - | - | - |
Amortization of route and customer acquisition costs and location contracts acquired | ||||||||||
5,565 | - | - | - | 4,303 | - | - | - | - | - | - |
Amortization of debt issuance costs | ||||||||||
472 | - | - | - | 205 | - | - | - | - | - | - |
Stock-based compensation | ||||||||||
1,060 | - | - | - | 128 | - | - | - | - | - | - |
(Gain) loss on disposal of property and equipment | ||||||||||
119 | - | - | - | 28 | - | - | - | - | - | - |
Loss on write-off of route and customer acquisition costs and route and customer acquisition costs payable | ||||||||||
-291 | - | - | - | -89 | - | - | - | - | - | - |
Remeasurement of contingent consideration | ||||||||||
-2,744 | - | - | - | 86 | - | - | - | - | - | - |
Payments on consideration payable | ||||||||||
1,520 | - | - | - | 0 | - | - | - | - | - | - |
Accretion of interest on route and customer acquisition costs payable, contingent consideration, and contingent stock consideration | ||||||||||
604 | - | - | - | 162 | - | - | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||||
Prepaid expenses and other current assets | ||||||||||
-656 | - | - | - | 2,802 | - | - | - | - | - | - |
Income taxes receivable | ||||||||||
0 | - | - | - | 589 | - | - | - | - | - | - |
Route and customer acquisition costs | ||||||||||
426 | - | - | - | 536 | - | - | - | - | - | - |
Route and customer acquisition costs payable | ||||||||||
131 | - | - | - | -25 | - | - | - | - | - | - |
Accounts payable and accrued expenses | ||||||||||
-11,260 | - | - | - | 6,911 | - | - | - | - | - | - |
Other assets | ||||||||||
-40 | - | - | - | 40 | - | - | - | - | - | - |
Net (loss) income attributable to ordinary shares | ||||||||||
- | - | - | - | - | - | 1,931 | 1,634 | 1,126 | -94 | -124 |
Prepaid expenses | ||||||||||
- | - | - | - | - | - | -37 | -41 | 17 | 38 | 127 |
Accrued professional fees, travel and other expenses | ||||||||||
- | - | - | - | - | - | -278 | 190 | 99 | 92 | 231 |
Interest on Investments held in Trust Account | ||||||||||
- | - | - | - | - | - | 2,069 | 1,801 | 1,414 | 0 | 0 |
Net cash (used in) provided by operating activities | ||||||||||
-4,349 | 48,967 | -3,581 | -17,720 | 17,900 | 44,112 | 371 | 65 | -206 | - | - |
Cash flows from investing activities: | ||||||||||
Purchases of property and equipment | ||||||||||
3,855 | - | - | - | 5,579 | - | - | - | - | - | - |
Proceeds from the sale of property and equipment | ||||||||||
121 | - | - | - | 28 | - | - | - | - | - | - |
Net cash used in operating activities | ||||||||||
- | - | - | - | - | - | - | - | - | - | -19 |
Proceeds deposited into Trust Account | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 450,000 |
Net cash used in investing activities | ||||||||||
-3,734 | - | - | - | -5,551 | - | - | - | - | - | - |
Cash flows from financing activities: | ||||||||||
Payments on term loan | ||||||||||
3,000 | - | - | - | 0 | - | - | - | - | - | - |
Proceeds from delayed draw term loans | ||||||||||
65,000 | - | - | - | 7,750 | - | - | - | - | - | - |
Payments on delayed draw term loans | ||||||||||
750 | - | - | - | 2,750 | - | - | - | - | - | - |
Net payments on line of credit | ||||||||||
-8,000 | - | - | - | -13,500 | - | - | - | - | - | - |
Payments for debt issuance costs | ||||||||||
325 | - | - | - | 0 | - | - | - | - | - | - |
Payments on consideration payable | ||||||||||
3,707 | - | - | - | 347 | - | - | - | - | - | - |
Payments on capital lease obligation | ||||||||||
0 | - | - | - | 372 | - | - | - | - | - | - |
Payment of underwriters discounts | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 9,000 |
Payment of accrued offering costs | ||||||||||
- | - | - | - | - | - | -4 | -65 | -19 | -258 | -69 |
Net cash used in investing activities | ||||||||||
- | - | - | - | - | - | - | - | - | - | -450,000 |
Proceeds from sale of Units in initial public offering | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 450,000 |
Proceeds from sale of Private Placement Warrants to Sponsor | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 11,000 |
Proceeds of notes payable from Sponsor | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 300 |
Repayment of notes payable from Sponsor | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 300 |
Net cash provided by (used in) financing activities | ||||||||||
49,218 | - | - | - | -9,219 | 46,211 | -4 | -65 | -19 | - | - |
Net increase in cash | ||||||||||
41,135 | - | - | - | 3,130 | - | - | - | - | - | - |
Supplemental disclosures of cash flow information: | ||||||||||
Interest, net of amount of capitalized | ||||||||||
3,737 | - | - | - | - | - | - | - | - | - | - |
Supplemental schedules of noncash investing and financing activities: | ||||||||||
Purchases of property and equipment in accounts payable and accrued liabilities | ||||||||||
7,290 | - | - | - | - | - | - | - | - | - | - |
Acquisition of businesses and assets: | ||||||||||
Net cash provided by (used in) financing activities | ||||||||||
- | - | - | - | - | - | - | - | - | - | 451,955 |
Net change in cash | ||||||||||
- | - | - | - | - | - | - | 0 | -225 | -298 | 1,935 |
Deferred underwriting compensation | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 15,750 |
Accrued offering costs | ||||||||||
- | - | - | - | - | - | - | -65 | 101 | -258 | 1,229 |